Feline enteric coronaviruses have three open reading frames (ORFs) in region 3 (3a, 3b, and 3c). All three ORFs were expressed with C-terminal eGFP and 3xFLAG tags in different cell lines and their localisation was determined. ORF 3a is predicted to contain DNA-binding and transcription activator domains, and it is localised in the nucleus and in the cytoplasm. ORF 3b is also predicted to contain DNA-binding and activator domains, and was found to localise in the mitochondrion. Besides that, in some of the non-infected and FIPV-infected cells nucleolar, perinuclear or nuclear membrane accumulation of the eGFP-tagged 3b was observed. The exact compartmental localisation of ORF 3c is yet to be determined. However, based on our co-localisation studies 3c does not seem to be localised in the ER-Golgi network, ERGIC or peroxisomes. The expression of 3c-eGFP is clearly cell type dependent, it is more stable in MARC 145 cells than in Fcwf-4 or CrFK cells, which might reflect in vivo stability differences of 3c in natural target cells (enterocytes vs. monocytes/macrophages).
Feline enteric coronavirus (FECV) infection is very common in domestic cats all around the world. Approximately 20 to 60% of cats show seropositivity to the virus. From the two serotypes of FECV, serotype I is more prevalent in the field, causing 80-95% of the infections. Serotype II FECVs are recombinant viruses in which the serotype I S gene and the surrounding regions are replaced by the equivalent canine coronavirus (CCoV) sequences (Herrewegh et al., 1998) .
FECV replication is mostly confined to the intestinal tract, and the infection is usually asymptomatic or may result in mild, self-limiting gastrointestinal disease. As estimated, in around 5% of FECV-infected animals, a progressive debilitating disease, feline infectious peritonitis (FIP) develops. FIP is characterised by very high mortality and it is currently the leading infectious cause of death among young domestic cats. It is generally accepted that the basic reason for the development of FIP syndromes is the enhanced replication rate of FIP virus (FIPV) in monocytes and macrophages. In the case of FECV/FIPV, the shifting of the focus of viral replication from the intestinal tract toward macrophages and monocytes usually goes hand in hand with deletions in the genomic regions 3 (Bálint et al., 2014; Borschensky and Reinacher, 2014; Olasz et al., 2017b) .
FECVs have three open reading frames (ORFs) in region 3 (Fig. 1A) . The ~70 amino acid 3a and 3b proteins are conserved among subspecies 1 alphacoronaviruses. Because of the lack of predicted hydrophobic helices, both are thought to be localised in the cytoplasm, although their functions and their role in viral replication are unknown so far (Kipar and Meli, 2014) .
The sequence of the ~240 residue ORF 3c suggests that it is a class III membrane protein (Kipar and Meli, 2014) . It seems that intact, deletion-free 3c is needed for FECV to replicate in the gut (Chang et al., 2010; Bálint et al., 2014; Porter et al., 2014) . Among the ORFs of region 3 ORF 3c is the best studied, yet experimental data regarding its localisation and function in the cells are scarce. It was found to be weakly expressed in Felis catus whole fetus-4 (Fcwf-4) cells and was suggested to localise in the endoplasmic reticulum (ER)/Golgi based on the similar distribution pattern found at the related transmissible gastroenteritis virus (TGEV) 3b protein (O'Connor and Brian, 1999; Hsieh et al., 2013) .
To gain additional data about the function of the proteins of FECV region 3, we expressed them in different cell lines and investigated them in silico with different prediction programs.
Materials and methods
Total RNA was purified with QIAamp Viral RNA Mini Kit (Qiagen, Hilden, Germany) from an anal swab of an otherwise healthy FECV-positive cat showing signs of diarrhoea. Region 3 of FECV was amplified with the FIP_3abc_ Fw and FIP_3abc_R primers (Table 1) using the OneStep RT-PCR Kit (Qiagen, Hilden, Germany) and the amplicon was purified with Nucleospin gel purification kit (Macherey-Nagel, Düren, Germany) according to the manufacturer's recommendation.
The three ORFs of region 3 were amplified with six cloning primers (Ma3af-Ma3cr) (Table 1) by the Phusion Hot Start II DNA Polymerase (Thermo Fisher Scientific, Waltham, USA) using the sequenced region 3 amplicon as template. Fragments encoding ORF3a-c were digested with XhoI and PstI enzymes and cloned into pEGFP-N1(Clontech, Fermont, USA) and p-MeGFPN1 (Olasz et al., 2016) vectors in frame with the eGFP protein and into the pcDNA-FLAG vector (Olasz et al., 2016) .
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The viral amplicon was sequenced by BigDye Terminator sequencing kit (Thermo Fisher Scientific, Waltham, USA) using the amplifying primers and the MaCo3 primers (Table 1) . Table 1 Primers applied in the studies Name Sequence
FIP_3abc_Fw 5'-AAT GGC CDT GGT ATG TGT-3' FIP_3abc_R 5'-CAT DCC ATK GTC RTC TAT-3' Ma3af 5'-GAC TGC TGG ATC CCT CGA GAC CAT GGA CAC TGT CAA GTC TAT TGG C-3' Ma3ar 5'-GAC TCT CGA GCT GCA GAA CAG TCG TAT GAT TAT GCG ACT C-3' Ma3bf 5'-GAC TGC TGG ATC CCT CGA GAC CAT GCC AAA CTT CAG CTG GAT ATT G-3' Ma3br 5'-GAC TCT CGA GCT GCA GTT TTC GCA CTG CGT TTA AAA TGG C-3' Ma3cf 5'-GAC TGC TGG ATC CCT CGA GAC CAT GAT TGG CGG ATT GTT CCT C-3' Ma3cr 5'-GAC TCT CGA GCT GCA GGG AAA CAT CAT AGA CAC GCG C-3' MaCo3 5'-TAA AGC TAA GAC AGT TGT TG-3'
Plasmid constructs were transfected into CrFK, Fcwf-4 and MARC-145 cells with Turbofect (Thermo Scientific, Waltham, USA) on 6-well plates according to the manufacturer's recommendation. The tissue culture adapted FIPV-DF2 strain (multiplicity of infection 3) was used for the infection of the transfected CrFK cells as it was described earlier (Bálint et al., 2012) .
For immunofluorescence (IF) detection, the cells were fixed with 300 μl 3% formaldehyde solution and were washed twice with 1 ml washing buffer [phosphate-buffered saline (PBS) 0.1% Tween 20]. After washing, they were incubated in Hoechst 33342 (1 μg/μl) for 1 h and washed again twice with washing buffer. In case of the 3c and the FLAG-labelled 3a constructs, the cells were incubated in 1% Triton-X for 30 min after fixation and (after washing) the ER and the Golgi intermediate compartment (ERGIC) of cells were stained using a 200fold diluted mouse anti-calreticulin IgG (Thermo Fisher Scientific, Waltham, USA), ERGIC-53(F-3) (Santa Cruz Biotechnology, Dallas, USA) and 100-fold diluted anti-ABCD IgG1 (Sigma-Aldrich, St. Louis, USA) for 1 h, respectively. The cells were washed again and incubated in 500-fold diluted, CF586-labelled, anti-mouse IgG (Thermo Fisher Scientific, Waltham, USA) and in Hoechst 33342 (1 μg/μl) for 1 h. To label intermediate-to-trans Golgi Lectin GS-II Alexa Fluor 647 conjugate (Thermo Fisher Scientific, Waltham, USA) was used in 300-fold dilution. Samples were examined under an Axio Observer D1 inverse fluorescence research microscope (Zeiss, Oberkochen, Germany).
For the immunoprecipitation of the eGFP fusion proteins, the Protein G Immunoprecipitation Kit (Sigma-Aldrich, St. Louis, USA) was used. Transfected cells from a 6-well plate were lysed in 600 μl 1xIP buffer with 0.1% SDS. To bind the eGFP proteins, 10 μl GFP Tag polyclonal antibody (Thermo Fisher Scientific, Waltham, USA) was added to the lysates. All other treatments to prepare the eGFP-tagged proteins for SDS-polyacrylamide gel electrophoresis (PAGE) were executed following the manufacturer's Basic Protocol recommendation. Immunoblot detection of the GFP fusion proteins on supported nitrocellulose membrane (Bio-Rad, Hercules, USA) after PAGE was carried out by using a monoclonal anti-eGFP antibody (Thermo Fisher Scientific, Waltham, USA) in a 500-fold dilution and horseradish-peroxidase-conjugated goat anti-mouse IgG (Southern Biotech, Birmingham, USA) in a 1000-fold dilution. The horseradish peroxidase activity was revealed with 3,3'-diaminobenzidine tetrahydrochloride (Sigma-Aldrich, St. Louis, USA) substrate according to the supplier's recommendations. The molecular weights of the expressed proteins were compared to the PageRuler Plus Protein Ladder (Thermo Fisher Scientific, Waltham, USA).
For protein function prediction, the NLS Mapper (Kosugi et al., 2009 ), NucPred (Brameier et al., 2007) , NLStradamus (Nguyen Ba et al., 2009) , Nine Amino Acids Transactivation Domain 9aaTAD Prediction Tool (Piskacek et al., 2007) , MITOPROT (Claros and Vincens, 1996) , PSFM-DBT (Zhang and Liu, 2017) , DP-Bind (Kuznetsov et al., 2006; Hwang et al., 2007) and the DRNApred (Yan and Kurgan, 2017) web servers were used.
Results
Since there was no available monospecific or monoclonal antibody against the proteins of FECV region 3, we decided to study them as GFP-and 3xFLAGtagged fusion proteins. First the three ORFs were amplified by PCR and cloned into a pEGFP-N1 vector and transfected into Fcwf-4 cells. After 36 h the cells were fixed and monitored under fluorescent microscope. Fluorescent signal could be detected inside the transfected cells indicating the translation of the GFP proteins. However, the localisation of the fusion proteins seemed to be very similar to that of the eGFP (nuclear and cytoplasmic) (Figs 2A-D), especially in the case of 3a and 3c (Figs 2A and C), though it was expected that at least the 3c-GFP fusion protein would localise in some membranous compartment of the cytoplasm. To characterise the expressed GFP fusion proteins, transfected cells of all three constructs were lysed and the fusion proteins were immunoprecipitated by an anti-eGFP polyclonal antibody and their sizes were analysed on Western blot by an anti-eGFP monoclonal antibody. Surprisingly, bands of equal size to eGFP (27 kDa) were detected in the lysates of all constructs ( Fig. 2E ). Moreover, they seemed to be the dominant bands except in the case of the 3a-eGFP construct, while no band with the expected size (54 kDa) was detected in the case of the 3c-eGFP construct ( Fig. 2E ). These findings suggest that native eGFP is translated from the fusion constructs that interferes with the detection of the viral fusion proteins and that 3c-eGFP is very weakly expressed in the transfected cells. To eliminate the interfering effect of the translated native eGFP, the three ORFs were cloned in the p-MeGFPN1 vector, which contains a mutation in the initia-tion codon of eGFP (Olasz et al., 2016) , thereby eliminating native eGFP translation. In these fusion constructs translation can be initiated only from the ATGs of the cloned ORFs. This approach proved to be successful and clear, eGFP background-free signals could be detected in the transfected cells that allowed us to determine the localisation of the 3a, 3b and 3c proteins (Figs 3, 4 and 5).
The 3a protein does not contain any short basic stretches of amino acids or any recognisable classical nuclear localisation signals (NLS), and no prediction programs (NLS Mapper, NucPred, NLStradamus (Brameier et al., 2007; Kosugi et al., 2009; Nguyen Ba et al., 2009 ) recognise such motifs on them. Yet, the majority of the 3a-eGFP protein is localised in the nucleus, though it can also be detected in the cytoplasm (Fig. 3A ). Since eGFP alone shows somewhat similar distribution in the CRFK cells (nuclear and cytoplasmic) ( Fig. 3B) , we also transfected a construct where the 3a protein was fused to a 3xFLAG-tag. Detection of the 3xFLAG-tag with anti-FLAG antibody verified the nuclear and the cytoplasmic localization of the 3a protein (Fig. 3C ). The nuclear localisation of the protein can indicate a DNA-or RNA-binding function, so we screened the protein sequence of 3a for the presence of DNA-or RNA-binding domains by various prediction programs, and in fact some of the programs predicted potential DNA-binding amino acids in the 3a protein (Fig. 1B) . The high net negative charge (pI 4.41) and strong hydrophobic character of the protein suggested the presence of a transcription activator domain (TAD) on 3a. In fact, analysis of the sequence with the Nine Amino Acids Transactivation Domain 9aaTAD Prediction Tool (Piskacek et al., 2007) revealed not one but two regions between amino acids 12-20 and 46-63 that could serve as a potential TAD (Fig. 1B) . In the majority of the cells 3b-eGFP protein was localised as a granular/speckled pattern in the cytoplasm strongly resembling mitochondrial localisation ( Fig. 4) . When the 72-amino-acid-long sequence of 3b was investigated by a computer program predicting mitochondrial transport (MITOPROT; Claros and Vincens, 1996) , an almost perfect score (probability 0.9982) was gained, further supporting mitochondrial localisation. To gain fool-proof results, the 3b-eGFP and 3b-3xFLAG constructs were co-transfected with the pDsRed2-Mito plasmid expressing the mitochondrial human cytochrome-c oxidase protein fused to the dsRed fluorescent protein. In the co-transfected cells the green and the red fluorescent signal co-localised, verifying that the 3b protein is indeed localised in the mitochondria (Fig. 4A-D and F) . Besides the mitochondrial localisation, in around one-third of the transfected cells the 3b-eGFP protein was also clearly visible in the nucleolus (Fig. 4B-D) . In a few transfected cells (1/100) very tight perinuclear accumulation or possibly nuclear membrane localisation of the 3b-eGFP labelled protein was observed. However, perinuclear 3b-eGFP did not colocalise with either the pDsRed2-Mito or the cytochrome-c mitochondrial markers ( Fig. 4C-D) . In the same ways as for the 3a protein, potential DNA binding regions and two minimally overlapping TAD domains were predicted at the amino-terminal of the protein (Fig. 1B) . The 3c protein showed very weak expression, and 3c-eGFP and 3c-3xFLAG fusion proteins could be detected (Fig. 5 ) in only a very small fraction of the CrFK cells (less than one in the hundreds). In these cells the fluorescent signal is localised in small point-like structures diffused in the cytoplasm that seemed to aggregate in a larger structure near the nucleus. Interestingly, the GFP signal did not co-localise with the signal of the ER marker calreticulin (Fig. 5A ), suggesting that 3c is not localised in the ER as it was suggested by Hsieh et al. (2013) . Localisation of the 3c protein was also investigated in the intermediateto-trans Golgi, in the peroxisome and in the ERGIC by staining the transfected cat-originated cell lines with Lectin GS-II binding α-and β-N-acetyl-Dglucosaminyl residues anti-ABCD3 (recognising peroxisome-resident ABCD3 protein) and anti-ERGIC antibodies. The 3c protein co-localised with neither the peroxisome nor the ERGIC markers ( Figs 5C-E) . Unfortunately, Lectin GS-II bound to neither Fcwf-4 nor CrFK cells (data not shown). To gain additional data about the localisation of 3c the 3c-eGFP-expressing construct was transfected into MARC-145 cells (originating from African green monkey kidney) in which Golgi is readily stained by Lectin GS-II. Surprisingly, 3c was expressed much more strongly in MARC-145 cells than in the established cat cell lines (detected in one tenth of the cells), but it showed similar distribution and localisation. Anti-ERGIC labelling of the transfected MARC 145 cells confirmed that 3c is not located in the ERGIC (Fig. 5D ), while Lectin GS-II labelling of the 3cexpressing cells revealed that the 3c protein does not localise in the Golgi either (Fig. 5B) .
To investigate the effect of other viral proteins on the localisation and stability of the proteins of region 3, CrFK cells were transfected with 3a-c expressing plasmids and the cells were infected with FIPV-DF2 6 h post transfection and fixed at 18 h post infection. At that time the effect of viral infection was clearly visible, manifesting itself in cytopathic effects, cell death and the formation of syncytia. Viral infection had no visible effect on the localisation of 3a and 3c either ( Figs 6A and D) , and 3c protein was expressed still very poorly in CrFK cells.
However, 3b can be detected much more frequently (~ 50%) in the nucleolus of infected non-syncytial cells than in that of the non-infected cells (data not shown). In infected syncytial cells this difference cannot be observed. The perinuclear or nuclear membrane localisation of 3b was also more frequent (1/10) in syncytial cells (Figs 6B-C).
Discussion
Many comparative diagnostic and experimental observations implicate ORF3abc in the pathogenesis of FIP, yet very little is known about the exact functions of this genetic region (Haijema et al., 2007; Pedersen, 2009) . In this study we determined the localisation of the proteins coded by the three ORFs of the region by tagging them with eGFP and 3xFLAG. Carboxy terminal tagging of the proteins was chosen because none of the utilised protein function and signal prediction programs predicted such functional units whose interaction with the carboxy terminal tag could potentially interfere with the localisation of proteins. The distribution of 3a-c was similar in the cells with both tags, suggesting A that the fusion partners do not influence artificially the localisations of the proteins. Despite these findings it cannot be excluded that the investigation of the native proteins with specific antibodies may reveal additional and more defined information about the function and localisation of these proteins. Viral RNAs are widely known for non-canonical translation initiation (it is not only the first ATG that serves as an initiation codon on the mRNA), and several mechanisms (e.g. leaky scanning, shunting, IRES, etc.) were identified in viral protein synthesis (O'Connor and Brian, 2000; Firth and Brierley, 2012) . Transient expression of the eGFP fusion constructs (made in pEGFP-N1 plasmids with functional eGFP initiation codon) in all cases resulted in high levels of native eGFP, that were detected in the cytoplasm and the nucleus of the transfected cells by immunofluorescence microscope and by Western blot (Fig. 2) . This result suggested that in all investigated FECV ORFs alternative initiation occurs and at least the first ATG codon downstream of these ORFs is able to initiate translation. Expressing the ORFs as eGFP fusion protein without functional eGFP initiation codon (in p-MeGFPN1 plasmid, a mutated derivative of pEGFP-N1) verified this suspicion, since the native eGFP background disappeared from the cytoplasm and from the nucleus of cells transfected with 3b-and 3c-eGFP constructs (Figs 4 and 5) . Furthermore, the finding that an internal entry mechanism is used for the expression of ORF 3b in the closely related TGEV (O'Connor and Brian, 2000) suggests that non-canonical translation initiation is generally used to translate the consecutive ORFs of the region 3 in alphacoronavirus 1 species (FECV, CCoV, TGEV, etc.) . The determination of the exact noncanonical mechanisms contributing to the translation of the region requires further investigations.
ORFs 3a and 3b are exclusive features of the subspecies of the alphacoronavirus 1 species. Proteins translated from the two ORFs were suggested to locate in the cytoplasm based on their predicted physicochemical characteristics (Kipar and Meli, 2014) . However, our experimental evidence contradicted this presumption.
Protein 3a is localised in the nucleus and in the cytoplasm (Figs 3A and C). Since it does not contain NLS, it is most probably transported to the nucleus by diffusion or complex formation (piggyback transport) with cellular proteins containing NLS. The localisation of the protein in multiple cellular compartments and the presence of predicted DNA binding and activator domains indicate pleiotropic functions of 3a that most probably involve the reprogramming of the transcriptional regulation of the infected cells. Viral proteins with similar multiple (cytosolic and nuclear) localisations were identified in several different viruses (e. g. 7ap of PRRSV, X protein of hepatitis B virus, μ2 of reovirus T1L (Mbisa et al., 2000; Henkler et al., 2001; Ma et al., 2011; Olasz et al., 2016 Olasz et al., , 2017a Rivera-Serrano et al., 2017) with proven nucleic acid binding and/or transcription regulating capabilities. Acta Veterinaria Hungarica 66, 2018 Protein 3b was found to localise in the mitochondrion and the nucleolus (Fig. 4) . With this feature, 3b is not unique among coronaviral accessory proteins. The non-homologous 154-aa-long 3b protein of the SARS-CoV, that is translated from an entirely differently organised region 3, was shown to localise in the mitochondria and in the nucleolus, and to inhibit type I interferon (IFN I) production (Yuan et al., 2006) . Besides its involvement in innate immunity modulation, the mitochondrial localisation of 3b may suggest an anti-or proapoptotic function of 3b. Since the mitochondrial pathway represents the main intrinsic signalling cascade for programmed cell death (Benedict et al., 2002) , several viruses (e.g. α-herpesviruses, adenoviruses, hepatitis C virus, influenza A virus) manipulate this pathway for their own advantage (White, 1998; Chung et al., 2003; You et al., 2017; Yeganeh et al., 2018) . The nucleolar localisation and presence of potential activator and DNA binding domains suggest a role of 3b in the regulation of translation through the influence of ribosome biogenesis in the infected cells. In some of the non-infected and in the FIPV-infected cells perinuclear or nuclear membrane accumulation of the 3b was observed (Figs 4B-D and 6B-C). The distribution of the 3b around the nucleus suggests an interaction of the protein with the nuclear pores or with the nuclear lamina. There are numerous reports about the interaction of the proteins of DNA viruses (e.g. herpesviruses and polyomaviruses) with the nuclear lamina (Cibulka et al., 2012) but (to our knowledge) such interaction has not yet been reported about the proteins of cytoplasmic (cp) RNA viruses. However, interaction was found among the proteins of several cpRNA viruses (Venezuelan equine encephalitis virus, picornaviruses) and the nuclear pore complex to regulate nucleocytoplasmic trafficking (Younessi et al., 2012; Le Sage and Mouland, 2013; Yarbrough et al., 2014) . These findings make it more likely that the 3b protein interacts with components of the nuclear pore. The fact that 3b alone shows perinuclear accumulation (Figs 4C-D) only in a few of the non-infected cells makes it highly probable that other viral protein(s) is/are also involved in the accumulation process during viral infection. The different ratios of 3b in the cellular compartments (mitochondrial, perinuclear and nucleolar) in the different stages of the cells (infected, noninfected and syncytial) could be the consequence of changing interactions of 3b with cellular and viral proteins during the successive steps of infection. However, further investigations are needed to clarify these presumptions.
The 3c protein of FECV is predicted to be a membrane protein and it is an orthologue (81% amino acid identity) of the 3b of TGEV. Both 3c and 3b of TGEV were shown to be very weakly expressed or instable in tissue culture cells and cannot be detected by Western blot (O'Connor and Brian, 2000; Hsieh et al., 2013) . Based on their fuzzy perinuclear localisation by IF, they were suggested to be localised in the ER-Golgi network. Our 3c-eGFP Western blot and IF experiments confirmed weak expression/instability of 3c in Fcwc-4 and CrFK cells. The exact compartmental localisation of 3c remained an enigma, it does not seem to be localised in the ER-Golgi network, ERGIC or peroxisomes (Fig. 5) . It was also shown by others that it is not involved in autophagy (Hsieh et al., 2013) . However, its localisation in the cytoplasmic compartments and aggregation in perinuclear region might indicate shuttling among or fusion of subcellular compartments. Interestingly, its expression in cell lines of non-host (non-human primate) origin largely increased the detectability of the 3c-eGFP protein by IF, raising the possibility that the quantity of the native 3c protein during FECV infection might also be different in host target cells (macrophages and enterocytes), and this difference may contribute to the deletion of the 3c region of the macrophage-specific FIPV (e.g. 3c might be overexpressed in enterocytes for an unknown biological function but underexpressed in macrophages and the deletion of its gene in FIPV does not cause further loss of biological function, because the coded functional protein is not there). Unfortunately, until further evidence emerges, these remarks remain only speculations, but our findings clearly indicate the necessity of in situ immunological investigations of 3c in native enterocytes and macrophages of FECV-infected cats.
